Related references
Note: Only part of the references are listed.Aurora kinase inhibitors in preclinical and clinical testing
Chun Hei Antonio Cheung et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2009)
Aurora kinases as anticancer drug targets
Oliver Gautschi et al.
CLINICAL CANCER RESEARCH (2008)
Expression of Aurora a (but not Aurora B) is predictive of survival in breast cancer
Yasmine Nadler et al.
CLINICAL CANCER RESEARCH (2008)
Dosing strategies for MLN8054, a selective Aurora A kinase inhibitor, based on pharmacokinetic modeling and simulations
Y. Lee et al.
EJC SUPPLEMENTS (2008)
Phase 1 study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of MLN8237, a selective Aurora A kinase inhibitor, in the United States
J. Infante et al.
EJC SUPPLEMENTS (2008)
MLN8237, an oral selective Aurora A kinase inhibitor: initial results of dose-finding pharmacokinetic-pharmacodynamic phase I study
J. Tabernero-Caturla et al.
EJC SUPPLEMENTS (2008)
Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients
Charles N. Landen et al.
CLINICAL CANCER RESEARCH (2007)
MLN8054, a small-molecule inhibitor of Aurora A, causes spindle pole and chromosome congression defects leading to aneuploidy
Kara Hoar et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Antitumor activity of MLN8054, an orally active small-molecule inhibitor of Aurora A kinase
Mark G. Manfredi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Targeted anti-mitotic therapies: can we improve on tubulin agents?
Jeffrey R. Jackson et al.
NATURE REVIEWS CANCER (2007)
Overexpression of aurora kinase A in mouse mammary epithelium induces genetic instability preceding mammary tumor formation
X. Wang et al.
ONCOGENE (2006)
Prognosis and gene expression profiling of 20q13-amplified breast cancers
Christophe Ginestier et al.
CLINICAL CANCER RESEARCH (2006)
Biological characteristics in bladder cancer depend on the type of genetic instability
Y Yamamoto et al.
CLINICAL CANCER RESEARCH (2006)
Aurora-kinase inhibitors as anticancer agents
N Keen et al.
NATURE REVIEWS CANCER (2004)
Cre-loxP-controlled periodic Aurora-A overexpression induces mitotic abnormalities and hyperplasia in mammary glands of mouse models
DW Zhang et al.
ONCOGENE (2004)
The cellular geography of aurora kinases
M Carmena et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2003)
Mitotic phosphorylation of histone H3: Spatio-temporal regulation by mammalian aurora kinases
C Crosio et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Tumour-amplified kinase BTAK is amplified and overexpressed in gastric cancers with possible involvement in aneuploid formation
C Sakakura et al.
BRITISH JOURNAL OF CANCER (2001)
Mitotic kinases as regulators of cell division and its checkpoints
EA Nigg
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
New guidelines to evaluate the response to treatment in solid tumors
F Duffaud et al.
BULLETIN DU CANCER (2000)
New guidelines to evaluate the response to treatment in solid Tumors
P Therasse et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
